Literature DB >> 24414388

Organism profile in periprosthetic joint infection: pathogens differ at two arthroplasty infection referral centers in Europe and in the United States.

Vinay K Aggarwal1, Hooman Bakhshi1, Niklas Unter Ecker2, Javad Parvizi1, Thorsten Gehrke2, Daniel Kendoff2.   

Abstract

Infecting microorganism is a strong predictor of treatment success for periprosthetic joint infection (PJI). The purpose of this study was to compare the infecting pathogens causing PJI at two large infection referral centers in the United States and in Europe. In this study, 898 consecutive cases of PJI were identified at the HELIOS ENDO-Klinik Hamburg in Europe and 772 cases were identified at the Rothman Institute in the United States. The incidence of organisms at the HELIOS ENDO-Klinik Hamburg versus the Rothman Institute was: coagulase-negative Staphylococcus (39.3 vs. 20.2%), S. aureus (13.0 vs. 31.0%), Streptococcus (6.5 vs. 5.8%), Enterococcus (7.0 vs. 3.9%), anaerobic (9.0 vs. 0.9%), fungal (0.3 vs. 2.3%), mycobacterial (0 vs. 0.6%), polymicrobial (3.4 vs. 7.4%), culture negative (16.1 vs. 15.8%), and other organisms (0.9 vs. 5.4%). The percentage of methicillin-resistant S. aureus was significantly higher at the American center than at the European center (48.1 vs. 12.8%; p < 0.0001). Our findings show higher virulence and resistance organisms are more prevalent at a referral center in the United States compared with one in Europe. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2014        PMID: 24414388     DOI: 10.1055/s-0033-1364102

Source DB:  PubMed          Journal:  J Knee Surg        ISSN: 1538-8506            Impact factor:   2.757


  51 in total

Review 1.  Current Recommendations for the Diagnosis of Acute and Chronic PJI for Hip and Knee-Cell Counts, Alpha-Defensin, Leukocyte Esterase, Next-generation Sequencing.

Authors:  Karan Goswami; Javad Parvizi; P Maxwell Courtney
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

2.  Infection post-total knee replacement: current concepts.

Authors:  Pouya Alijanipour; Javad Parvizi
Journal:  Curr Rev Musculoskelet Med       Date:  2014-06

3.  Microorganisms responsible for periprosthetic knee infections in England and Wales.

Authors:  Richard J Holleyman; Paul Baker; Andre Charlett; Kate Gould; David J Deehan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-04-01       Impact factor: 4.342

4.  16S rRNA analysis provides evidence of biofilms on all components of three infected periprosthetic knees including permanent braided suture.

Authors:  Matthew C Swearingen; Alex C DiBartola; Devendra Dusane; Jeffrey Granger; Paul Stoodley
Journal:  Pathog Dis       Date:  2016-08-21       Impact factor: 3.166

5.  Expect the Unexpected: Mycobacterial Infection in Post Total Knee Arthroplasty Patients.

Authors:  Vikram Kishor Kandhari; Mohan M Desai; Roshan N Wade; Surendar S Bava
Journal:  J Clin Diagn Res       Date:  2017-01-01

Review 6.  The Impact of Incorporating Antimicrobials into Implant Surfaces.

Authors:  N J Hickok; I M Shapiro; A F Chen
Journal:  J Dent Res       Date:  2017-09-18       Impact factor: 6.116

7.  [Septic arthritis in adults].

Authors:  J Loock; N Haustedt; J Wollenhaupt
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

8.  In Vitro Study of the Synergistic Effect of an Enzyme Cocktail and Antibiotics against Biofilms in a Prosthetic Joint Infection Model.

Authors:  Hervé Poilvache; Albert Ruiz-Sorribas; Olivier Cornu; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

9.  Acute arrest of hematopoiesis induced by infection with Staphylococcus epidermidis following total knee arthroplasty: A case report and literature review.

Authors:  Lintao Bi; Jun Li; Zhenxia Lu; Hui Shao; Ying Wang
Journal:  Exp Ther Med       Date:  2016-01-25       Impact factor: 2.447

Review 10.  Fighting Staphylococcus aureus Biofilms with Monoclonal Antibodies.

Authors:  Dina Raafat; Michael Otto; Kevin Reppschläger; Jawad Iqbal; Silva Holtfreter
Journal:  Trends Microbiol       Date:  2019-01-19       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.